Clinical trial
DIALYSIS-TIR Study
NCT06042153
Study timeline
Study start (actual)2023-12-05Date precision: day
Registry last updated2026-01-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
End Stage Renal Disease on Dialysisunresolved
Interventions
SemaglutideDRUG · verified · RxNorm: semaglutide
PlaceboDRUG
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
University of North Carolina, Chapel Hillcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06042153 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.